0001209191-19-026318.txt : 20190426
0001209191-19-026318.hdr.sgml : 20190426
20190426200420
ACCESSION NUMBER: 0001209191-19-026318
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190425
FILED AS OF DATE: 20190426
DATE AS OF CHANGE: 20190426
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kherani Aftab
CENTRAL INDEX KEY: 0001584373
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 19773388
MAIL ADDRESS:
STREET 1: C/O AISLING CAPITAL III, LP
STREET 2: 888 SEVENTH AVENUE, 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRANSENTERIX INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 635 DAVIS DRIVE
STREET 2: SUITE 300
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
FORMER COMPANY:
FORMER CONFORMED NAME: CELLULAR TECHNICAL SERVICES CO INC
DATE OF NAME CHANGE: 19930328
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-25
0
0000876378
TRANSENTERIX INC.
TRXC
0001584373
Kherani Aftab
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
1
0
0
0
Common Stock
2019-04-25
4
A
0
20380
0.00
A
21419
D
Stock Option Award
1.96
2019-04-25
4
A
0
29104
0.00
A
2029-04-25
Common Stock
29104
29104
D
Represents restricted stock units. Each restricted stock unit represents the right to receive one share of the Registrant's common stock.
The restricted stock units remain subject to forfeiture until the first anniversary of the date of grant or, if earlier, the date of the next annual meeting of stockholders, as long as the reporting person remains in continuous service during the vesting period.
Amount of securities beneficially owned following reported transaction reflects the required assignment by the reporting person to an affiliated fund of the right to receive 20,362 shares of common stock upon vesting, on April 24, 2019, of RSUs granted to the reporting person on May 24, 2018.
The vesting schedule is 25% of the stock option award on July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020. Subject to acceleration of vesting in full upon consummation of a change in control of the registrant.
/s/ Joshua Weingard attorney-in-fact for Aftab Kherani
2019-04-26